Track the Sonoma Pharmaceuticals, Inc. share price and the full directors' dealings record of the company, a listed equity based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Market capitalisation: €5.3m. The latest transaction was reported on 21 June 2024 (Attribution). Among the most active insiders: Thornton Bruce. The full history is free.
6
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 27,891 of 28,802 companies
12.7
score / 100
Value
3
Quality
23
FCF yld-78%
Earn yld-60%
EV/EBITDA·
ROE-85%
Gross mgn38%
Net mgn-16%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
100,000 sharesCommon Stock, $0.0001 par valueSEC:0001683168-23-004631:0
6 of 6 declarations
About Sonoma Pharmaceuticals, Inc.
Sonoma Pharmaceuticals, Inc. is a company focused on developing pharmaceutical products for the treatment of skin diseases. It is listed on the NASDAQ under the symbol SNOA.